Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study.

"Conflict of interest E. Hommel received consulting fees as a member of scientific advisory boards from Medtronic. B. Olsen received honoraria for lectures from Medtronic and Novo Nordisk, and consulting fees as a member of scientific advisory boards from Novo Nordisk. T. Battelino’s institution received research grant support, with receipt of travel and accommodation expenses in some cases, from Abbott, Medtronic, Novo Nordisk, GluSense, and Diamyd. T. Battelino received honoraria for participating on the speaker’s bureaux of Eli Lilly, Novo Nordisk, Bayer, and Medtronic; and consulting fees as a member of scientific advisory boards from Bayer, Life Scan, Eli Lilly, Sanofi-Aventis, and Medtronic. I. Conget received honoraria for lectures and consulting fees as a member of scientific advisory boards from Medtronic, Bayer, GSK, Eli Lilly, NovoNordisk, Sanofi-Aventis, Novartis, and MSD. I. Schütz-Fuhrmann received honoraria for lectures and consulting fees as a member of scientific advisory boards from Eli Lilly, Novo Nordisk, Sanofi-Aventis, Bayer, Medtronic, Roche, and Med Trust. R. Hoogma received honoraria for lectures and consulting fees as a member of scientific advisory boards from Roche AG, Sanofi-Aventis, Medtronic, and MSD. U. Schierloh received travel and accommodation reimbursement from Medtronic, Novo Nordisk, and Lifescan. N. Sulli’s Regional Diabetes Centre received research grant support for scholarship, with receipt of travel and accommodation expenses in some cases, from Medtronic, Novo Nordisk, and Roche. H. Gough is a full-time employee of Medtronic International Trading Sarl. J. Castaneda is a full-time employee of Medtronic Bakken Research Center and holds shares in Medtronic Inc. S. de Portu is a full-time employe of Medtronic International Trading Sarl. J. Bolinder received honoraria for lectures from Abbott Diabetes Care, Medtronic, and Sanofi-Aventis; and consulting fees as a member of scientific advisory boards from Abbott Diabetes Care, AstraZeneca, Medtronic, and MSD."

"The SWITCH Study Group includes; T. Battelino, I. Conget, B. Olsen, I. Schutz, E. Hommel, R. Hoogma, U. Schierloh, N Sulli, J. Bolinder, N. Bratina, M. Gimenez, C. de Beaufort, R. Prager, L. Tarnow, F. Tillemans, and B. Shashaj. The Study Group would like to acknowledge M. Vidal, S. Cvach, A. M. Hertz, Y. Rayane, and I. Zupancic for clinical assistance in the conduct of the study, C. Kollman, Jaeb Center for Health Research, for his review and comment on the statistical analysis plan. The SWITCH study was funded by Medtronic International Trading Sarl, Tolochenaz, Switzerland. Medical writing assistance in the preparation of this paper was provided by Dr Michael Shaw (MScript Ltd., Hove, UK)."